healthcare

Allied Market Research recently published a report, titled, " Head & Neck Cancer Drugs Market  by Drug Class (Chemotherapy, Immunotherapy, and Targeted Therapy) and Sales Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Stores): Global Opportunity Analysis and Industry Forecast, 2018 – 2025." The report offers an extensive analysis of key market segments, top winning strategies, research methodology, evolving market trends, key segments, list of key players, market size & estimations, and competitive landscape. According to the report, the global head & neck cancer drugs market was estimated at  $1.2 billion  in 2017 and is expected to hit  $2.2 billion  in 2025, registering a CAGR of 7.3% from 2018-2025. Request Sample Report at:   https://www.alliedmarketresearch.com/request-sample/5174 Recent launch of advance drugs for treatment of head and neck cancer ,   increase in global geriatric populat...

Electrocardiograph (ECG) is a non-invasive medical test that records the electrical activity of the heartbeat over a period of time. ECG monitoring devices such as, resting ECG, stress ECG, and holter monitors help identify and provide information about abnormal functioning of the heart. Global ECG Market  was valued at $4,516 million in 2016, and is expected to reach $6,637 million by 2023, registering a CAGR of 5.6% from 2017 to 2023. Cardiovascular disease is one of the most common health problems faced by people across the globe, with high mortality rate accounting for approximately 370,000 people deaths annually in the U.S. alone. This propels the demand for ECG market as the increase in number of ECG tests are conducted by people, susceptible to heart diseases. Download Sample of the Report @ https://www.alliedmarketresearch.com/request-sample/3372 The other key factors that boost the growth of electrocardiograph (ECG) market include technological advancemen...

Metallic biomaterials segment is expected to contribute significantly to the global market revenue until 2022. North America held the leading position in the global market in 2015, and is expected to maintain its lead throughout the study period. The global  biomaterials market  is estimated to reach $139 Billion by 2022, growing at a CAGR of 11.8% from 2016 to 2022. Metallic biomaterials segment contributed the highest revenue share to the global market, owing to highly used in orthopedic treatments for bone support and replacement, due to their strength and resistance to fatigue degradation. Polymeric biomaterials segment is projected to grow at a CAGR of 13.0% from 2016 to 2022, due to increasing demand for biodegradable products, and their use in various applications due their unique features such as flexibility, lightweight, remarkable biocompatibility, and physical & mechanical properties. Download Sample of the Report @ https://www.alliedmarketre...